Thrombosis et diathesis haemorrhagica, 0340-6245

Tidskrift

Fler filtreringsmöjligheter
  1. Protein Z and protein Z-dependent protease inhibitor - Determinants of levels and risk of venous thrombosis

    Al-Shanqeeti, A., Vlieg, AV., Erik Berntorp, Rosendaal, FR. & Broze, GJ., 2005, I : Thrombosis and Haemostasis. 93, 3, s. 411-413

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Value of ventilation/perfusion SPECT detecting extensive pulmonary embolism in a patient with pneumonia.

    Marika Bajc, Olsson, C-G., Björn Jonson & Albrechtsson, U., 2005, I : Thrombosis and Haemostasis. 93, 5, s. 993-994

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives

    Erik Berntorp, Escuriola-Ettingshausen, C., Khair, K., Kreuz, W., Montano, C. & Zozulya, N., 2011, I : Thrombosis and Haemostasis. 105, 3, s. A4-A14

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  4. No increased risk of venous thrombosis in women taking tranexamic acid

    Erik Berntorp, Follrud, C. & Lethagen, S., 2001, I : Thrombosis and Haemostasis. 86, 2, s. 714-715

    Forskningsoutput: TidskriftsbidragLetter

  5. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome

    Blanchet, X., Cesarek, K., Brandt, J., Heiko Herwald, Teupser, D., Kuechenhoff, H., Karshovska, E., Mause, S. F., Siess, W., Wasmuth, H., Soehnlein, O., Koenen, R. R., Weber, C. & von Hundelshausen, P., 2014, I : Thrombosis and Haemostasis. 112, 6, s. 1277-1287

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.

    Oscar Braun, Angiolillo, D. J., Ferreiro, J. L., Jakubowski, J. A., Winters, K. J., Effron, M. B., Duvvuru, S., Costigan, T. M., Sundseth, S., Walker, J. R., Saucedo, J. F., Kleiman, N. S. & Varenhorst, C., 2013, I : Thrombosis and Haemostasis. 110, 6, s. 1223-1231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

    Oscar Braun, Johnell, M., Varenhorst, C., James, S., Brandt, J. T., Jakubowski, J. A., Winters, K. J., Wallentin, L., David Erlinge & Siegbahn, A., 2008, I : Thrombosis and Haemostasis. 100, 4, s. 626-633

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]

    Briet, E., Rosendaal, F. R., Kreuz, W., Rasi, V., Peerlinck, K., Vermylen, J., R. Ljung, Rocino, A., Addiego, J. & Lorenzo, J. I., 1994 nov 25, I : Thrombosis and Haemostasis. 72, 1, s. 162-164

    Forskningsoutput: TidskriftsbidragLetter

  9. Platelets: a new target for gene therapy of haemophilia B.

    Brown, M. A., 2002, I : Thrombosis and Haemostasis. 87, 3, s. 362-363

    Forskningsoutput: TidskriftsbidragLetter

  10. Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation

    Calzavarini, S., Villoutreix, B. O., Lunghi, B., Livaja Koshiar, R., Bernardi, F. & Björn Dahlbäck, 2013, I : Thrombosis and Haemostasis. 110, 1, s. 31-38

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Platelet adhesion in polytetrafluoroethylene (PTFE) vascular grafts in vivo and the influence of increased intramuscular pressure - An experimental model.

    Christensson, J., Qvarfordt, P., Strand, S-E., Arvidsson, D., Trygve Sjöberg & Olsson, P-I., 1983, I : Thrombosis and Haemostasis. 50, 4, s. 881-884

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. The tale of protein S and C4b-binding protein, a story of affection

    Björn Dahlbäck, 2007, I : Thrombosis and Haemostasis. 98, 1, s. 90-96

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions

    Dickneite, G., Heiko Herwald, Korte, W., Allanore, Y., Denton, C. P. & Cerinic, M. M., 2015, I : Thrombosis and Haemostasis. 113, 4, s. 686-697

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  14. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls

    Emmerich, J., Rosendaal, F. R., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V., Andreas Hillarp & Reny, J-L., 2001, I : Thrombosis and Haemostasis. 86, 3, s. 809-816

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

    David Erlinge, James, S., Duvvuru, S., Jakubowski, J. A., Wagner, H., Varenhorst, C., Tantry, U. S., Brown, P. B., Small, D., Moser, B. A., Sundseth, S., Walker, J. R., Winters, K. J. & Gurbel, P. A., 2014, I : Thrombosis and Haemostasis. 111, 5, s. 943-950

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. The dual role of the contact system in bacterial infectious disease

    Inga-Maria Frick, Lars Björck & Heiko Herwald, 2007, I : Thrombosis and Haemostasis. 98, 3, s. 497-502

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Genetic aspects of thrombotic disease

    Garcia de Frutos, P. & Bengt Zöller, 2015, I : Thrombosis and Haemostasis. 114, 5, s. 883-884

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  18. Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?

    Giangrande, P., von Depka, M., Kessler, C. M., Kannicht, C. & Rolf Ljung, 2011, I : Thrombosis and Haemostasis. 106, 3, s. 5-14

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen

    Giri, T. K., Andreas Hillarp, Härdig, Y., Bengt Zöller & Björn Dahlbäck, 1998, I : Thrombosis and Haemostasis. 79, 4, s. 767-772 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. The importance of genetic factors for the development of arthropathy: A longitudinal study of children and adolescents with haemophilia A

    Gomperts, E. D., Schwarz, J., Donfield, S. M., Lail, A. E., Jan Astermark, Keith Hoots, W., Winkler, C. A. & Erik Berntorp, 2017, I : Thrombosis and Haemostasis. 117, 2, s. 277-285 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Haplotype analysis of identical factor IX mutants using PCR

    Green, P. M., Montandon, A. J., R. Ljung, Giannelli, F. & Nilsson, I. M., 1992, I : Thrombosis and Haemostasis. 67, 1, s. 66-69

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Translational platelet research in patients with coronary artery disease: hat are the rnalor knowledge gaps?

    Gurbel, P. A., Roe, M. T., Jakubowski, J. A., Shah, S., David Erlinge, Goodman, S. G., Huber, K., Chan, M. Y., Cornel, J. H., Tantry, U. S. & Ohman, E. M., 2012, I : Thrombosis and Haemostasis. 108, 1, s. 12-20

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  23. The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

    Gurbel, P. A., Bergmeijer, T. O., Tantry, U. S., ten Berg, J. M., Angiolillo, D. J., James, S., Lindahl, T. L., Peter Svensson, Jakubowski, J. A., Brown, P. B., Duvvuru, S., Sundseth, S., Walker, J. R., Small, D., Moser, B. A., Winters, K. J. & David Erlinge, 2014, I : Thrombosis and Haemostasis. 112, 3, s. 589-597

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia

    He, S., Ezban, M., Bark, N., Persson, E. & Hedner, U., 2009, I : Thrombosis and Haemostasis. 102, 4, s. 790-792

    Forskningsoutput: TidskriftsbidragLetter

  25. Control of smooth muscle cell proliferation - The role of the basement membrane

    Hedin, U., Roy, J., Tran, P. K., K. Lundmark & Rahman, A., 1999 dec 1, I : Thrombosis and Haemostasis. 82, SUPPL. 1, s. 23-26 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. FactorVIIa and its potential therapeutic use in bleeding-associated pathologies

    Hedner, U., 2008, I : Thrombosis and Haemostasis. 100, 4, s. 557-562

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Anti-inflammatory, anti-coagulant, anti-biotic?

    Heiko Herwald, 2013, I : Thrombosis and Haemostasis. 109, 4, s. 582-582

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  28. Haemostasis, vascular biology, and infectious agents.

    Heiko Herwald, 2007, I : Thrombosis and Haemostasis. 98, 3, s. 483-484

    Forskningsoutput: TidskriftsbidragLetter

  29. Paracelsus, poison, and colistin

    Heiko Herwald, 2017, I : Thrombosis and Haemostasis. 117, 9, s. 1661 1 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  30. Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme.

    Andreas Hillarp, Egberg, N., Nordin, G., Stigendal, L., Fagerberg, I. & Lindahl, T. L., 2004, I : Thrombosis and Haemostasis. 91, 2, s. 300-307

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.

    Högberg, C., Olof Gidlöf, Deflorian, F., Jacobson, K. A., Abdelrahman, A., Müller, C. E., Björn Olde & David Erlinge, 2012, I : Thrombosis and Haemostasis. 108, 1, s. 119-132

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome

    Johan Holm, Andreas Hillarp, Bengt Zöller, Erhardt, L. RW., Erik Berntorp & Björn Dahlbäck, 1999, I : Thrombosis and Haemostasis. 81, 6, s. 857-860 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin

    Jan Holst, Lindblad, B., Matthíasson, S. E., Stjernquist, U., Ezban, M., Østergaard, P. B. & Hedner, U., 1996 apr, I : Thrombosis and Haemostasis. 75, 4, s. 585-589

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis: A comparison with low molecular weight heparin

    J. Holst, Lindblad, B., Bergqvist, D., Nordfang, O., Ostergaard, P. B., Petersen, J. G. L., Nielsen, G. & Hedner, U., 1994, I : Thrombosis and Haemostasis. 71, 2, s. 214-219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man

    Hrafnkelsdottir, T., David Erlinge & Jern, S., 2001, I : Thrombosis and Haemostasis. 85, 5, s. 875-881

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. A large deletion identified in a Swedish family with type 1 VWD

    Johansson, A. M., Lanke, E., Torbjörn Säll, Lethagen, S. & Halldén, C., 2011, I : Thrombosis and Haemostasis. 105, 4, s. 733-734

    Forskningsoutput: TidskriftsbidragLetter

  37. Large deletions of the PROS1 gene in a large fraction of mutationnegative patients with protein S deficiency

    Johansson, A., Andreas Hillarp, Torbjörn Säll, Bengt Zöller, Björn Dahlbäck & Halldén, C., 2005, I : Thrombosis and Haemostasis. 94, 5, s. 951-957

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura

    D Karpman, Lethagen, S., Kristoffersson, A., Isaksson, C. & Lars Holmberg, 1997 dec, I : Thrombosis and Haemostasis. 78, 6, s. 1456-62 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)

    Agnete Kirkeby, Torup, L., Bochsen, L., Kjalke, M., Abel, K., Theilgaard-Monch, K., Johansson, P. I., Bjørn, S. E., Gerwien, J. & Leist, M., 2008 apr, I : Thrombosis and Haemostasis. 99, 4, s. 720-728 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3.

    Kohler, S., Hallström, T., Singh, B., Kristian Riesbeck, Sparta, G., Zipfel, P. F. & Hammerschmidt, S., 2015, I : Thrombosis and Haemostasis. 113, 1, s. 125-142

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Low soluble thrombomodulin activity and antigen is associated with a family history of heart disease while a high level is associated with a personal history of heart disease in type 2 diabetes

    Konstantoulas, C. J., Cooper, J. A., Öhlin, A-K., Humphries, S. E., Goodall, A. H., Toh, C-H., Mather, H. & Ireland, H., 2007, I : Thrombosis and Haemostasis. 97, 1, s. 161-164

    Forskningsoutput: TidskriftsbidragLetter

  42. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

    Lallukka, S., Luukkonen, P. K., Zhou, Y., Isokuortti, E., Leivonen, M., Juuti, A., Hakkarainen, A., Marju Orho-Melander, Lundbom, N., Olkkonen, V. M., Lassila, R. & Yki-Järvinen, H., 2017, I : Thrombosis and Haemostasis. 117, 2, s. 286-294 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.

    Lanke, E., Ann-Charlotte Kristoffersson, Philips, M., Lars Holmberg & Lethagen, S., 2008, I : Thrombosis and Haemostasis. 100, 2, s. 211-216

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes

    Lethagen, S., Andreas Hillarp, Ekholm, C., Mattson, E., Halldén, C. & Britt Friberg, 2008, I : Thrombosis and Haemostasis. 99, 6, s. 1013-1018

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).

    Lethagen, S., Isaksson, C., Schaedel, C. & Lars Holmberg, 2002, I : Thrombosis and Haemostasis. 88, 3, s. 421-426

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples

    Lindahl, TL., Egberg, N., Andreas Hillarp, Odegaard, OR., Edlund, B., Svensson, J., Sandset, PM. & Ranby, M., 2004, I : Thrombosis and Haemostasis. 91, 6, s. 1223-1231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency

    Lind-Hallden, C., Dahlen, A., Andreas Hillarp, Bengt Zöller, Björn Dahlbäck & Hallden, C., 2012, I : Thrombosis and Haemostasis. 108, 1, s. 94-100

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa